Genelux Announces Promising Data From Two Phase I Trials of GL-ONC1 in Head & Neck Cancer and Mesothelioma

… for mesothelioma patients, … with late-stage disease (IVA or … cancer, from malignant pleural mesothelioma (MPM), non-small cell lung cancer (NSCLC), or breast cancer … death and triggers immune activation and memory for long-term immunotherapy against cancer …